PG
BLU

Pendal Group’s BELLUS Health Inc. BLU Stock Holding History

Pendal Group’s Portfolio BLU Stock Details BLU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$1.04M Buy
127,569
+99,241
+350% +$925K 0.01% 281
2022
Q3 		$299K Buy
+28,328
New +$301K ﹤0.01% 394

Other funds holding BLU

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
PCOC
Power Corp of Canada Montreal, Quebec, Canada $745M AUM 22.7% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Pendal Group's BLU Position: Q4 2022 in Review

Pendal Group increased its BELLUS Health Inc. (BLU) stake by 350% in Q4 2022, buying an estimated $925K and bringing the position to 127,569 shares worth $1.04M. The position accounts for 0.01% of the portfolio, ranked #281.

Pendal Group first reported a position in BLU in Q3 2022 and has held it in 2 quarters since. 121 funds tracked by Wall St. Rank hold BLU as of Q4 2022.

  • Pendal Group held 127,569 shares of BELLUS Health Inc. worth $1.04M as of Q4 2022.
  • Pendal Group bought 99,241 BELLUS Health Inc. shares in Q4 2022, an estimated $925K.
  • BELLUS Health Inc. made up 0.01% of Pendal Group's portfolio in Q4 2022, its #281 holding.
  • Pendal Group first reported a position in BELLUS Health Inc. in Q3 2022 and has held it in 2 quarters since.
  • 121 funds tracked by Wall St. Rank held BELLUS Health Inc. as of Q4 2022.

Based on Pendal Group's 13F filing for Q4 2022, filed 19 Jan 2023.